NASDAQ
3.47USD
-0.06 (-1.70%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
276.4M
P/E
—
EPS
—
Beta
2.10
52W range
3.12-11.29
Day range
3.46–3.63
Open
3.51
Prev close
3.53
Volume
961.2K
Avg volume
853.3K
Dividend
0.00
IPO
2015-06-24
https://seekingalpha.com/article/4930308-niagen-bioscience-inc-nage-q2-2026-earnings-call-transcript · 8/4/2026+0.00
https://www.businesswire.com/news/home/20260716002772/en/Niagen-Bioscience-Appoints-Abhijit-Kale-Ph.D.-as-Senior-Director-of-Global-External-Research/ · 7/16/2026+0.20
https://www.zacks.com/stock/news/2785057/niagen-bioscience-nage-surpasses-q3-earnings-and-revenue-estimates?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_4-2785057 · 11/5/2025+0.80
https://www.zacks.com/stock/news/2779062/niagen-bioscience-nage-reports-next-week-what-to-expect?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_9-2779062 · 10/28/2025+0.20
https://www.businesswire.com/news/home/20251021852088/en/Niagen-Bioscience-to-Report-Third-Quarter-2025-Financial-Results-on-Tuesday-November-4-2025/ · 10/21/2025
Niagen Bioscience Inc operates as a biotechnology enterprise with a core focus on promoting healthy aging. This company is also renowned for its pioneering research into nicotinamide adenine dinucleotide.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
